Interview with Miomir Nikolic, Managing Director, Zdravlje Actavis
Throughout its history, Zdravlje Actavis has grown into one of the 3 companies that really define Serbian pharma. What have been the main factors that got Actavis into this leading…
Address: Djordja Stanojevica 12, 11 070 Novi Beograd, Srbija,
Tel: +381 11 20 99 300
Web: http://www.actavis.rs/sr/default.htm
A leading manufacturer of drugs for gastroenterology and cardiology for more than 50 years, Zdravlje has been part of Actavis Group since 2002 and continues to be one of the largest generic pharmaceutical companies in Serbia. Based in Leskovac, this EU GMP certified company is proud of its highly trained and committed personnel. With a portfolio of mainly solid oral dosages strenghtened with the choice of modern generic products transferred from Actavis’ broad portfolio, Zdravlje Actavis company maintains a strong position in its home market, breaking new grounds in the EU markets. Actavis d.o.o. (Sales & Marketing Office for Serbia and Montenegro region): a branch office for Sales and Marketing was established in Belgrade at the beginning of 2005. It continues to consolidate Actavis’ work in the region, spearheading a strategic expansion of product sales and the marketing of Zdravlje Actavis, along with the introduction of Actavis product portfolio on the markets in Serbia and Montenegro.
drugs
Throughout its history, Zdravlje Actavis has grown into one of the 3 companies that really define Serbian pharma. What have been the main factors that got Actavis into this leading…
In a market environment that, up until recently, has been severely difficult for producers of chemical pharmaceutical products to operate in, three enterprising Serbian companies – Pharmanova, INNventa and Esensa…
Between 2010 and 2012 just one of the 139 new medicines to receive market authorisations globally was approved for reimbursement in Serbia, compared with 44 in Bulgaria and 27 in…
Nebojsa Skuljec has held various positions in MSD Healthcare across the Balkans before his promotion to country lead for Serbia and Balkans emerging markets 14 months ago. In this interview…
Branislav Kotlarik, Ferring’s general manager for the Balkans – whose remit includes Hungary, Romania and Bulgaria as well as all of ex-Yugoslavia – gives his insights into managing such a…
Gordana Zdravkovic has overseen the progression of BIOTEC International, Serbia through thick and thin. With over 25 years’ experience in the life sciences industry, she has put together a fantastic…
By reorganizing their management structure, diversifying their offering and presenting an altogether cleaner image, AstraZeneca Serbia has made tremendous progress since its beginnings in the Balkans in the late 1990s.…
Dragan Odzaklijevic, CEO of acb, the exclusive correspondent of leading global insurance broker Aon in Serbia, discusses the Serbian insurance market, which of acb’s services are most in demand for…
Nenad Djordjevic, managing director of Esensa, introduces the Belgrade company’s 200-strong portfolio of medical devices, food supplements, cosmetics and general use items; how it is now exporting its ‘made in…
Ana Grujovic, executive director of the Swiss-Serbian Chamber of Commerce (SSCC) who has been overseeing Swiss-Serbian business relations since 2014, explains the successful progression of the Chamber since its establishment,…
Ana Popovic, general manager of Serbia’s generics association, Genezis, gives her thoughts on how the generics industry has progressed in the country, what room for improvement remains, and the impact…
Suzana Djordjevic, director of the Hemofarm Foundation in Serbia, explores the themes of collectivism, social care and how individual acts can have profound outcomes in today’s world. Having enjoyed a…
Ljubiša Mitof-Višurski, general manager for AbbVie Adria, discusses the main challenges, opportunities and synergies the Adria region has to offer. He underlines the key healthcare initiatives AbbVie engages with in…
See our Cookie Privacy Policy Here
